stockrowMyomo, Inc. (MYO) vs Xtant Medical Holdings, Inc. (XTNT)
- Myomo, Inc. MYO 1.21 +1.68%
- Xtant Medical Holdings, Inc. XTNT 0.28 −6.67%
Myomo, Inc. and Xtant Medical Holdings, Inc. are both Medical Devices companies. Myomo, Inc. is the larger, with a market value of $47.1M against $42.1M — 1.1× the size. Myomo, Inc. grew revenue faster over the last twelve months: 6.14% against −14.3%. Xtant Medical Holdings, Inc. has the higher net margin (−10.2% vs −33.5%) and the higher return on invested capital (−12.4% vs −167.9%). Across the 18 metrics below, Xtant Medical Holdings, Inc. leads on 13 and Myomo, Inc. on 5.
Valuation
Profitability
| Metric | MYO | XTNT | Medical Devices median |
|---|---|---|---|
| Gross margin | 68.35% | 59.39% | 57.76% |
| Operating margin | (27.05%) | (9.58%) | (15.07%) |
| Net margin | (33.53%) | (10.17%) | (14.45%) |
| Free cash flow margin | (21.01%) | (0.42%) | (3.88%) |
| Return on equity | (123.76%) | (25.16%) | (10.35%) |
| Return on assets | (39.20%) | (12.16%) | (17.26%) |
| Return on invested capital | (167.90%) | (12.43%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack